Vivos (RDGL) Share-based Compensation Growth (1y) (2011 - 2025)
Vivos (RDGL) Share-based Compensation Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.03 Bn | 175.74 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 129.38 Bn | 126.50 Bn | 3.81 Bn | 37.62% |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn | 12.94% |
| 6 | Dexcom | 28.64 Bn | 27.52 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | 59.09% |
| 8 | Smith & Nephew | 27.02 Bn | 26.44 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | -30.44% |
| 10 | Vivos | 27.57 Mn | 26.01 Mn | -3,105.00 | 16.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.16% |
| Sep 30, 2025 | -80.97% |
| Jun 30, 2025 | 24.99% |
| Mar 31, 2025 | -50.56% |
| Dec 31, 2022 | 378.36% |
| Mar 31, 2018 | -98.41% |
| Sep 30, 2017 | -11.46% |
| Jun 30, 2017 | -95.37% |
| Mar 31, 2015 | 161.47% |
| Dec 31, 2014 | 373.77% |
| Sep 30, 2014 | -16.92% |
| Mar 31, 2014 | 39.74% |
| Dec 31, 2013 | -77.27% |
| Sep 30, 2013 | -99.17% |
| Jun 30, 2013 | 46.08% |
| Mar 31, 2013 | -97.83% |
| Dec 31, 2012 | 327.66% |
| Mar 31, 2012 | 1,895.24% |
| Dec 31, 2011 | -31.13% |